Loss of DCC Gene Expression in Osteosarcoma
Author Information
Author(s): MA Horstmann, M Posl, RB Scholz, B Anderegg, P Simon, K Baumgaertl, G Delling, H Kabisch
Primary Institution: University Hospital Eppendorf
Hypothesis
The DCC gene may be involved in the pathogenesis of osteosarcoma due to frequent allelic loss on chromosome 18.
Conclusion
The study found that DCC gene expression is frequently reduced or lost in high-grade osteosarcomas, suggesting its role as a tumor suppressor.
Supporting Evidence
- DCC expression was lost or substantially reduced in 14 of 19 high-grade osteosarcomas.
- Immunohistochemical studies correlated well with RT-PCR results.
- Loss of DCC expression may confer a growth advantage to cancer cells.
Takeaway
The DCC gene, which helps control cell growth, is often missing or not working properly in a type of bone cancer called osteosarcoma.
Methodology
The study analyzed mRNA and protein expression of the DCC gene in 25 osteosarcoma specimens and several tumor cell lines using RT-PCR and immunohistochemistry.
Limitations
The study did not assess all possible mutations or alterations in the DCC gene due to its large size.
Participant Demographics
The study included 25 human osteosarcoma specimens from 22 patients, with a mix of high-grade and low-grade tumors.
Want to read the original?
Access the complete publication on the publisher's website